BioSpace News Archive

Eclipse Bioinnovations, Inc. announced the completion of exclusive and co-exclusive licenses for intellectual property related to RNA structure probing, ribosome occupancy, and RNA modifications.

Rightway, the healthcare company reinventing care navigation and pharmacy benefits, announced its integration with Mark Cuban Cost Plus Drug Company, marking the first time a Pharmacy Benefit Manager has added the pharmacy to its network.

Quest Diagnostics Incorporated announced that it will report third quarter 2022 financial results on Thursday, October 20, 2022 , before the market opens.

PacBio announced the availability of a new computational analysis method for profiling more than a million tandem repeats across the human genome using PacBio’s native long-read HiFi sequencing data.

Aditxt, Inc. provides shareholders with a corporate update following the completion of a reverse stock split and closing of a previously announced $20 million public offering.

Aridis Pharmaceuticals, Inc. today announced that due to adverse market conditions, it has withdrawn its proposed public offering of shares of its common stock.

Cynata Therapeutics Limited (ASX: “CYP” or “Cynata”), a clinical-stage biotechnology company specialising in cell therapeutics, is delighted to announce that the Australian Government National Health and Medical Research Council (NHMRC) has awarded a grant of approximately $1 million under the NHMRC 2021 MRFF Cardiovascular Health Mission

Progentec announced today that Marc Jones, seasoned healthcare industry executive, has joined Progentec’s Board of Directors.

BerGenBio ASA announced today that the first patient has been included in a study of BerGenBio’s oral, highly selective AXL inhibitor, bemcentinib.

Radionetics Oncology announced the appointment of Umesh Gangadharmath, Ph.D. as Senior Vice President, Technical Operations.